Low-level laser therapy improves crescentic glomerulonephritis in rats.

Area of Science:

• Nephrology
• Immunology
• Biomedical Engineering

Background:

• Low-level laser therapy (LLLT) is recognized for its anti-inflammatory effects in various clinical conditions.
• The impact of LLLT on internal organ inflammation, particularly in kidney diseases, remains largely unexplored.
• Crescentic glomerulonephritis is a severe kidney disease characterized by rapid inflammation and potential kidney failure.

Purpose of the Study:

• To investigate the anti-inflammatory efficacy of daily external LLLT.
• To evaluate LLLT's effect on an established animal model of crescentic glomerulonephritis.
• To determine if LLLT can mitigate kidney damage and inflammatory markers.

Main Methods:

• Crescentic glomerulonephritis was induced in Wistar Kyoto rats via anti-glomerular basement membrane (GBM) antibody injection.
• Rats received daily external LLLT (830 nm infrared laser) for 14 days.
• Inflammation, crescent formation, cytokine gene expression (IL-1β, TNF-α), and immune cell infiltration were assessed.

Main Results:

• LLLT significantly suppressed crescent formation in glomeruli.
• External LLLT reduced the infiltration of macrophages (ED1+) and lymphocytes (CD8+) into the kidneys.
• LLLT treatment attenuated the messenger RNA levels of key inflammatory cytokines, IL-1β and TNF-α, in the renal cortex.

Conclusions:

• Daily external LLLT demonstrates a significant anti-inflammatory and protective effect against anti-GBM antibody-induced crescentic glomerulonephritis in rats.
• LLLT effectively reduces key pathological features and inflammatory markers associated with this severe kidney disease.
• These findings suggest that LLLT holds potential as a non-invasive therapeutic strategy for treating glomerulonephritis.